Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kenya National AIDS & STI Control Programme | OTHER |
| Ministry of Medical Services, Kenya | OTHER |
| EngenderHealth | OTHER |
| Cornell University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this research study is to evaluate the safety and acceptability of the Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device with a potential role in the safe and cost-effective delivery of circumcision services. The device, developed in China, consists of two concentric plastic rings. Following a ring penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is everted over the inner ring and the larger outer ring is secured over the inner ring. The foreskin is excised and several nicks are made on the incision line to prevent formation of a constricting, circumferential scab. No suturing is required.
In this study, the investigators will evaluate wound healing of men randomized to removal of the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the device on for 14 or 21 days constitutes extended wear of the device.
Sites: Homa Bay District Hospital, Nyanza Province, Kenya
The objective of this research study is to evaluate the safety and acceptability of the Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device with a potential role in the safe and cost-effective delivery of circumcision services. The device, developed in China, consists of two concentric plastic rings. Following a ring penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is everted over the inner ring and the larger outer ring is secured over the inner ring. The foreskin is excised and several nicks are made on the incision line to prevent formation of a constricting, circumferential scab. No suturing is required.
In this study, we will evaluate wound healing of men randomized to removal of the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the device on for 14 or 21 days constitutes extended wear of the device.
Although male circumcision has a demonstrated protective effect against HIV transmission, currently available surgical techniques and devices have limitations for widespread deployment in resource-poor areas. High costs and scarcity of trained providers hinder access to male circumcision services in resource-poor areas. Its simple design sets the Shang Ring apart from other male circumcision techniques. The Shang Ring has the potential for safe, effective and inexpensive delivery of male circumcision by trained healthcare personnel in HIV endemic countries.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Day 7 | Other | removal of Shang Ring at 7 days |
|
| Day 14 | Other | removal of Shang Ring at 14 days |
|
| Day 21 | Other | removal of Shang Ring at 21 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Shang Ring | Device | The Shang Ring is a sterile device consisting of two concentric medical grade plastic rings: an inner ring with a silicone band and an outer, hinged ring. The inner ring fits inside the outer ring which will lock when snapped together. The Shang Ring comes in multiple sizes. The appropriate size is determined through use of a measuring strip. The man must return to the clinic for device removal. To remove the device, the outer ring locking mechanism is broken open using a tool that is similar to a scalpel handle. Then, a pair of special scissors, specifically designed for this purpose, is used to remove the inner ring after healing |
| Measure | Description | Time Frame |
|---|---|---|
| Asses healing time | Assess healing time from date of circumcision | six weeks |
| spontaneous detachment of device | Spontaneous detachment from date of circumcision to three weeks post procedure | 21 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marc Goldstein, M.D. | Weill Cornell Medical College, NY, USA | Study Chair |
| Mark Barone, DVM; MS | EngenderHealth, NY, USA | Study Chair |
| Philip S. Li, MD | Weill Medical College of Cornell University | Principal Investigator |
| Puneet Masson, MD | Weill Medical College of Cornell University | Principal Investigator |
| Paul Perchal, MA | EngenderHealth | Principal Investigator |
| Jared Moguche, MB ChB | EngenderHealth | Principal Investigator |
| Quentin Awori, MB ChB | Engender Health | Principal Investigator |
| Peter Cherutich, MB ChB MPH | National AIDS/STD Control Programme, Nairobi, Kenya | Principal Investigator |
| Nicholas Muraguri, MB ChB MPH | National AIDS/STD Control Programme | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Homa Bay District Hospital | Homa Bay | Nyanza | 40300 | Kenya |
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| John Masasabi Wekesa, MB ChB MMed |
| Ministry of Medical Services Nairobi Kenya |
| Principal Investigator |
| Robert Otieno Simba, MMed | Homa Bay District Hospital | Principal Investigator |